DarioHealth Corp. (DRIO) |
| 7.26 0.23 (3.27%) 04-17 16:00 |
| Open: | 7.27 |
| High: | 7.4 |
| Low: | 7.24 |
| Volume: | 4,489 |
| Market Cap: | 53(M) |
| PE Ratio: | -0.72 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 9.55 |
| Resistance 1: | 8.27 |
| Pivot price: | 7.51 |
| Support 1: | 6.20 |
| Support 2: | 5.16 |
| 52w High: | 17.744 |
| 52w Low: | 5.935 |
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
| EPS | -10.120 |
| Book Value | 9.840 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.964 |
| Profit Margin (%) | -186.57 |
| Operating Margin (%) | -163.68 |
| Return on Assets (ttm) | -20.0 |
| Return on Equity (ttm) | -59.6 |
Tue, 14 Apr 2026
DarioHealth Corp. (NASDAQ:DRIO) Short Interest Update - MarketBeat
Mon, 13 Apr 2026
DarioHealth (DRIO) director reports owning 4,500 common shares - Stock Titan
Mon, 13 Apr 2026
John R. Palumbo appointed to DarioHealth board - TradingView
Mon, 13 Apr 2026
Veteran executive joins DarioHealth (NASDAQ: DRIO) board to drive scaling - Stock Titan
Mon, 13 Apr 2026
Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling - Sahm
Mon, 30 Mar 2026
DarioHealth (NASDAQ: DRIO) launches $20M ATM offering with A.G.P. - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |